Sponsor or institution

Clinical trials and research at Pierre Fabre Medicament

• 5Clinical trials
• 14Countries

Newest trials

All recruiting trials (5)

• Testing VERT-002 in patients with advanced solid tumors and MET alterations

  This study is testing a new drug called VERT-002 to see if it can help people with advanced solid tumors that have specific changes in their genes, especially those with non-small cell lung cancer, who have run out of other treatment options.

  Recruiting at 19 sites Phase 1/2 Pierre Fabre Medicament · Washington D.C., District of Columbia and 18 other locations · NCT06669117

• Testing a new drug for advanced lung cancer resistant to previous treatments

  This study is testing a new drug for people with advanced lung cancer that hasn’t responded to previous treatments to see if it can help them.

  Recruiting at 18 sites Phase 1/2 Pierre Fabre Medicament · Nashville, Tennessee and 17 other locations · NCT06567015

• Testing STX-721 for advanced lung cancer with specific mutations

  This study is testing a new treatment called STX-721 to see if it can help people with advanced lung cancer that has specific mutations feel better and respond to the therapy.

  Recruiting at 32 sites Phase 1/2 Pierre Fabre Medicament · Duarte, California and 31 other locations · NCT06043817

• Evaluating KIN-2787 for patients with specific tumor mutations

  This study is testing a new drug called KIN-2787 to see if it can help adults with advanced cancers that have certain gene mutations, like those found in lung cancer and melanoma.

  Recruiting at 43 sites Phase 1 Pierre Fabre Medicament · Los Angeles, California and 47 other locations · NCT04913285

• Treatment for Epstein-Barr Virus-Associated Lymphoproliferative Disease After Transplant

  This study is testing a new treatment called tabelecleucel for patients with a specific type of cancer related to Epstein-Barr virus who haven't improved with other therapies after receiving a transplant.

  Recruiting at 35 sites Phase 3 Pierre Fabre Medicament · Duarte, California and 70 other locations · NCT03394365

Quick answers

How many clinical trials run by Pierre Fabre Medicament are recruiting right now?

5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 14 countries. The most sites are in France (5 trials), Spain (5 trials), United States (5 trials), Taiwan (4 trials), Australia (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 3, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →